APO Research
Talk to an analyst

APO RESEARCH · REPORT

Olprinone Hydrochloride Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Olprinone Hydrochloride Injection Market Outlook and Growth Opportunities 2026

26 December 2025190 pages

Choose your research edition.

Industry ResearchOlprinone Hydrochloride Injection Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Olprinone Hydrochloride Injection Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Olprinone Hydrochloride Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Olprinone Hydrochloride Injection Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Olprinone Hydrochloride Injection Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Olprinone Hydrochloride Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Olprinone Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Olprinone Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Olprinone Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Olprinone Hydrochloride Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Olprinone Hydrochloride Injection market include BioHippo, Cayman Chemical, DC Chemicals, Vinci Biochem srl, Dequan Pharmaceutical (Jiangsu) Co., Ltd., Sinopharm Rongsheng Pharmaceutical Co., Ltd., Hunan Hengsheng Pharmaceutical Co., Ltd., Jilin Sichang Pharmaceutical Co., Ltd. and Jichuang Pharmaceutical Group Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Olprinone Hydrochloride Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Olprinone Hydrochloride Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Olprinone Hydrochloride Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Olprinone Hydrochloride Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Olprinone Hydrochloride Injection Segment by Company

BioHippo

Cayman Chemical

DC Chemicals

Vinci Biochem srl

Dequan Pharmaceutical (Jiangsu) Co., Ltd.

Sinopharm Rongsheng Pharmaceutical Co., Ltd.

Hunan Hengsheng Pharmaceutical Co., Ltd.

Jilin Sichang Pharmaceutical Co., Ltd.

Jichuang Pharmaceutical Group Co., Ltd.

Ruiyang Pharmaceutical Co., Ltd.

Shandong Qidu Pharmaceutical Co., Ltd.

Shanxi Deyuantang Pharmaceutical Co., Ltd.

Shenyang Shuangding Pharmaceutical Co., Ltd.

Wuhu Yangyan Pharmaceutical Co., Ltd.

Zhongfu Pharmaceutical Co., Ltd.

Olprinone Hydrochloride Injection Segment by Type

10 Pieces/Box

5 Pieces/Box

Olprinone Hydrochloride Injection Segment by Application

Hospital

Clinic

Other

Olprinone Hydrochloride Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Olprinone Hydrochloride Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Olprinone Hydrochloride Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Olprinone Hydrochloride Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Olprinone Hydrochloride Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Olprinone Hydrochloride Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Olprinone Hydrochloride Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Olprinone Hydrochloride Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Olprinone Hydrochloride Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Olprinone Hydrochloride Injection industry.

Chapter 3: Detailed analysis of Olprinone Hydrochloride Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Olprinone Hydrochloride Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Olprinone Hydrochloride Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Olprinone Hydrochloride Injection Industry Trends Table 2. Olprinone Hydrochloride Injection Industry Drivers Table 3. Olprinone Hydrochloride Injection Industry Opportunities and Challenges Table 4. Olprinone Hydrochloride Injection Industry Restraints Table 5. Global Olprinone Hydrochloride Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Olprinone Hydrochloride Injection Revenue Share by Company (2021-2026) Table 7. Global Olprinone Hydrochloride Injection Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Olprinone Hydrochloride Injection Sales Volume Share by Company (2021-2026) Table 9. Global Olprinone Hydrochloride Injection Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Olprinone Hydrochloride Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Olprinone Hydrochloride Injection Key Company Manufacturing Base & Headquarters Table 12. Global Olprinone Hydrochloride Injection Company, Product Type & Application Table 13. Global Olprinone Hydrochloride Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Olprinone Hydrochloride Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 10 Pieces/Box Table 18. Significant Companies of 5 Pieces/Box Table 19. Global Olprinone Hydrochloride Injection Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Olprinone Hydrochloride Injection Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Olprinone Hydrochloride Injection Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Olprinone Hydrochloride Injection Sales Volume Share by Type (2021-2026) Table 23. Global Olprinone Hydrochloride Injection Sales Volume Share by Type (2027-2032) Table 24. Global Olprinone Hydrochloride Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Olprinone Hydrochloride Injection Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Olprinone Hydrochloride Injection Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Olprinone Hydrochloride Injection Sales Value Share by Type (2021-2026) Table 28. Global Olprinone Hydrochloride Injection Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Other Table 32. Global Olprinone Hydrochloride Injection Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Olprinone Hydrochloride Injection Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Olprinone Hydrochloride Injection Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Olprinone Hydrochloride Injection Sales Volume Share by Application (2021-2026) Table 36. Global Olprinone Hydrochloride Injection Sales Volume Share by Application (2027-2032) Table 37. Global Olprinone Hydrochloride Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Olprinone Hydrochloride Injection Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Olprinone Hydrochloride Injection Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Olprinone Hydrochloride Injection Sales Value Share by Application (2021-2026) Table 41. Global Olprinone Hydrochloride Injection Sales Value Share by Application (2027-2032) Table 42. Global Olprinone Hydrochloride Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Olprinone Hydrochloride Injection Sales by Region (2021-2026) & (K Units) Table 44. Global Olprinone Hydrochloride Injection Sales Market Share by Region (2021-2026) Table 45. Global Olprinone Hydrochloride Injection Sales by Region (2027-2032) & (K Units) Table 46. Global Olprinone Hydrochloride Injection Sales Market Share by Region (2027-2032) Table 47. Global Olprinone Hydrochloride Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Olprinone Hydrochloride Injection Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Olprinone Hydrochloride Injection Sales Value Share by Region (2021-2026) Table 50. Global Olprinone Hydrochloride Injection Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Olprinone Hydrochloride Injection Sales Value Share by Region (2027-2032) Table 52. Global Olprinone Hydrochloride Injection Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Olprinone Hydrochloride Injection Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Olprinone Hydrochloride Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Olprinone Hydrochloride Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Olprinone Hydrochloride Injection Sales by Country (2021-2026) & (K Units) Table 57. Global Olprinone Hydrochloride Injection Sales Market Share by Country (2021-2026) Table 58. Global Olprinone Hydrochloride Injection Sales by Country (2027-2032) & (K Units) Table 59. Global Olprinone Hydrochloride Injection Sales Market Share by Country (2027-2032) Table 60. Global Olprinone Hydrochloride Injection Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Olprinone Hydrochloride Injection Sales Value Market Share by Country (2021-2026) Table 62. Global Olprinone Hydrochloride Injection Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Olprinone Hydrochloride Injection Sales Value Market Share by Country (2027-2032) Table 64. BioHippo Company Information Table 65. BioHippo Business Overview Table 66. BioHippo Olprinone Hydrochloride Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. BioHippo Olprinone Hydrochloride Injection Product Portfolio Table 68. BioHippo Recent Development Table 69. Cayman Chemical Company Information Table 70. Cayman Chemical Business Overview Table 71. Cayman Chemical Olprinone Hydrochloride Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Cayman Chemical Olprinone Hydrochloride Injection Product Portfolio Table 73. Cayman Chemical Recent Development Table 74. DC Chemicals Company Information Table 75. DC Chemicals Business Overview Table 76. DC Chemicals Olprinone Hydrochloride Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. DC Chemicals Olprinone Hydrochloride Injection Product Portfolio Table 78. DC Chemicals Recent Development Table 79. Vinci Biochem srl Company Information Table 80. Vinci Biochem srl Business Overview Table 81. Vinci Biochem srl Olprinone Hydrochloride Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Vinci Biochem srl Olprinone Hydrochloride Injection Product Portfolio Table 83. Vinci Biochem srl Recent Development Table 84. Dequan Pharmaceutical (Jiangsu) Co., Ltd. Company Information Table 85. Dequan Pharmaceutical (Jiangsu) Co., Ltd. Business Overview Table 86. Dequan Pharmaceutical (Jiangsu) Co., Ltd. Olprinone Hydrochloride Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Dequan Pharmaceutical (Jiangsu) Co., Ltd. Olprinone Hydrochloride Injection Product Portfolio Table 88. Dequan Pharmaceutical (Jiangsu) Co., Ltd. Recent Development Table 89. Sinopharm Rongsheng Pharmaceutical Co., Ltd. Company Information Table 90. Sinopharm Rongsheng Pharmaceutical Co., Ltd. Business Overview Table 91. Sinopharm Rongsheng Pharmaceutical Co., Ltd. Olprinone Hydrochloride Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Sinopharm Rongsheng Pharmaceutical Co., Ltd. Olprinone Hydrochloride Injection Product Portfolio Table 93. Sinopharm Rongsheng Pharmaceutical Co., Ltd. Recent Development Table 94. Hunan Hengsheng Pharmaceutical Co., Ltd. Company Information Table 95. Hunan Hengsheng Pharmaceutical Co., Ltd. Business Overview Table 96. Hunan Hengsheng Pharmaceutical Co., Ltd. Olprinone Hydrochloride Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Hunan Hengsheng Pharmaceutical Co., Ltd. Olprinone Hydrochloride Injection Product Portfolio Table 98. Hunan Hengsheng Pharmaceutical Co., Ltd. Recent Development Table 99. Jilin Sichang Pharmaceutical Co., Ltd. Company Information Table 100. Jilin Sichang Pharmaceutical Co., Ltd. Business Overview Table 101. Jilin Sichang Pharmaceutical Co., Ltd. Olprinone Hydrochloride Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Jilin Sichang Pharmaceutical Co., Ltd. Olprinone Hydrochloride Injection Product Portfolio Table 103. Jilin Sichang Pharmaceutical Co., Ltd. Recent Development Table 104. Jichuang Pharmaceutical Group Co., Ltd. Company Information Table 105. Jichuang Pharmaceutical Group Co., Ltd. Business Overview Table 106. Jichuang Pharmaceutical Group Co., Ltd. Olprinone Hydrochloride Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Jichuang Pharmaceutical Group Co., Ltd. Olprinone Hydrochloride Injection Product Portfolio Table 108. Jichuang Pharmaceutical Group Co., Ltd. Recent Development Table 109. Ruiyang Pharmaceutical Co., Ltd. Company Information Table 110. Ruiyang Pharmaceutical Co., Ltd. Business Overview Table 111. Ruiyang Pharmaceutical Co., Ltd. Olprinone Hydrochloride Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Ruiyang Pharmaceutical Co., Ltd. Olprinone Hydrochloride Injection Product Portfolio Table 113. Ruiyang Pharmaceutical Co., Ltd. Recent Development Table 114. Shandong Qidu Pharmaceutical Co., Ltd. Company Information Table 115. Shandong Qidu Pharmaceutical Co., Ltd. Business Overview Table 116. Shandong Qidu Pharmaceutical Co., Ltd. Olprinone Hydrochloride Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Shandong Qidu Pharmaceutical Co., Ltd. Olprinone Hydrochloride Injection Product Portfolio Table 118. Shandong Qidu Pharmaceutical Co., Ltd. Recent Development Table 119. Shanxi Deyuantang Pharmaceutical Co., Ltd. Company Information Table 120. Shanxi Deyuantang Pharmaceutical Co., Ltd. Business Overview Table 121. Shanxi Deyuantang Pharmaceutical Co., Ltd. Olprinone Hydrochloride Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Shanxi Deyuantang Pharmaceutical Co., Ltd. Olprinone Hydrochloride Injection Product Portfolio Table 123. Shanxi Deyuantang Pharmaceutical Co., Ltd. Recent Development Table 124. Shenyang Shuangding Pharmaceutical Co., Ltd. Company Information Table 125. Shenyang Shuangding Pharmaceutical Co., Ltd. Business Overview Table 126. Shenyang Shuangding Pharmaceutical Co., Ltd. Olprinone Hydrochloride Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Shenyang Shuangding Pharmaceutical Co., Ltd. Olprinone Hydrochloride Injection Product Portfolio Table 128. Shenyang Shuangding Pharmaceutical Co., Ltd. Recent Development Table 129. Wuhu Yangyan Pharmaceutical Co., Ltd. Company Information Table 130. Wuhu Yangyan Pharmaceutical Co., Ltd. Business Overview Table 131. Wuhu Yangyan Pharmaceutical Co., Ltd. Olprinone Hydrochloride Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Wuhu Yangyan Pharmaceutical Co., Ltd. Olprinone Hydrochloride Injection Product Portfolio Table 133. Wuhu Yangyan Pharmaceutical Co., Ltd. Recent Development Table 134. Zhongfu Pharmaceutical Co., Ltd. Company Information Table 135. Zhongfu Pharmaceutical Co., Ltd. Business Overview Table 136. Zhongfu Pharmaceutical Co., Ltd. Olprinone Hydrochloride Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Zhongfu Pharmaceutical Co., Ltd. Olprinone Hydrochloride Injection Product Portfolio Table 138. Zhongfu Pharmaceutical Co., Ltd. Recent Development Table 139. Key Raw Materials Table 140. Raw Materials Key Suppliers Table 141. Olprinone Hydrochloride Injection Distributors List Table 142. Olprinone Hydrochloride Injection Customers List Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Olprinone Hydrochloride Injection Product Image Figure 2. Global Olprinone Hydrochloride Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Olprinone Hydrochloride Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Olprinone Hydrochloride Injection Sales (2021-2032) & (K Units) Figure 5. Global Olprinone Hydrochloride Injection Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Olprinone Hydrochloride Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 10 Pieces/Box Image Figure 10. 5 Pieces/Box Image Figure 11. Global Olprinone Hydrochloride Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Olprinone Hydrochloride Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Olprinone Hydrochloride Injection Sales Volume Share by Type (2021-2032) Figure 14. Global Olprinone Hydrochloride Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Olprinone Hydrochloride Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Olprinone Hydrochloride Injection Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Other Image Figure 20. Global Olprinone Hydrochloride Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Olprinone Hydrochloride Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Olprinone Hydrochloride Injection Sales Volume Share by Application (2021-2032) Figure 23. Global Olprinone Hydrochloride Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Olprinone Hydrochloride Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Olprinone Hydrochloride Injection Sales Value Share by Application (2021-2032) Figure 26. Global Olprinone Hydrochloride Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Olprinone Hydrochloride Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Olprinone Hydrochloride Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Olprinone Hydrochloride Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Olprinone Hydrochloride Injection Sales Value (2021-2032) & (US$ Million) Figure 31. North America Olprinone Hydrochloride Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Olprinone Hydrochloride Injection Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Olprinone Hydrochloride Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Olprinone Hydrochloride Injection Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Olprinone Hydrochloride Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Olprinone Hydrochloride Injection Sales Value (2021-2032) & (US$ Million) Figure 37. South America Olprinone Hydrochloride Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Olprinone Hydrochloride Injection Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Olprinone Hydrochloride Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Olprinone Hydrochloride Injection Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Olprinone Hydrochloride Injection Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 10 Pieces/Box
  • 5 Pieces/Box
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • BioHippo
  • Cayman Chemical
  • DC Chemicals
  • Vinci Biochem srl
  • Dequan Pharmaceutical (Jiangsu) Co., Ltd.
  • Sinopharm Rongsheng Pharmaceutical Co., Ltd.
  • Hunan Hengsheng Pharmaceutical Co., Ltd.
  • Jilin Sichang Pharmaceutical Co., Ltd.
  • Jichuang Pharmaceutical Group Co., Ltd.
  • Ruiyang Pharmaceutical Co., Ltd.
  • Shandong Qidu Pharmaceutical Co., Ltd.
  • Shanxi Deyuantang Pharmaceutical Co., Ltd.
  • Shenyang Shuangding Pharmaceutical Co., Ltd.
  • Wuhu Yangyan Pharmaceutical Co., Ltd.
  • Zhongfu Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Olprinone Hydrochloride Injection Sales Value (2021-2032)
  4. 1.2.2 Global Olprinone Hydrochloride Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Olprinone Hydrochloride Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Olprinone Hydrochloride Injection Market Dynamics
  1. 2.1 Olprinone Hydrochloride Injection Industry Trends
  2. 2.2 Olprinone Hydrochloride Injection Industry Drivers
  3. 2.3 Olprinone Hydrochloride Injection Industry Opportunities and Challenges
  4. 2.4 Olprinone Hydrochloride Injection Industry Restraints
3 Olprinone Hydrochloride Injection Market by Company
  1. 3.1 Global Olprinone Hydrochloride Injection Company Revenue Ranking in 2025
  2. 3.2 Global Olprinone Hydrochloride Injection Revenue by Company (2021-2026)
  3. 3.3 Global Olprinone Hydrochloride Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Olprinone Hydrochloride Injection Average Price by Company (2021-2026)
  5. 3.5 Global Olprinone Hydrochloride Injection Company Ranking (2024-2026)
  6. 3.6 Global Olprinone Hydrochloride Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Olprinone Hydrochloride Injection Company Product Type and Application
  8. 3.8 Global Olprinone Hydrochloride Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Olprinone Hydrochloride Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Olprinone Hydrochloride Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Olprinone Hydrochloride Injection Market by Type
  1. 4.1 Olprinone Hydrochloride Injection Type Introduction
  2. 4.1.1 10 Pieces/Box
  3. 4.1.2 5 Pieces/Box
  4. 4.2 Global Olprinone Hydrochloride Injection Sales Volume by Type
  5. 4.2.1 Global Olprinone Hydrochloride Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Olprinone Hydrochloride Injection Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Olprinone Hydrochloride Injection Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Olprinone Hydrochloride Injection Sales Value by Type
  9. 4.3.1 Global Olprinone Hydrochloride Injection Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Olprinone Hydrochloride Injection Sales Value by Type (2021-2032)
  11. 4.3.3 Global Olprinone Hydrochloride Injection Sales Value Share by Type (2021-2032)
5 Olprinone Hydrochloride Injection Market by Application
  1. 5.1 Olprinone Hydrochloride Injection Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Olprinone Hydrochloride Injection Sales Volume by Application
  6. 5.2.1 Global Olprinone Hydrochloride Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Olprinone Hydrochloride Injection Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Olprinone Hydrochloride Injection Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Olprinone Hydrochloride Injection Sales Value by Application
  10. 5.3.1 Global Olprinone Hydrochloride Injection Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Olprinone Hydrochloride Injection Sales Value by Application (2021-2032)
  12. 5.3.3 Global Olprinone Hydrochloride Injection Sales Value Share by Application (2021-2032)
6 Olprinone Hydrochloride Injection Regional Sales and Value Analysis
  1. 6.1 Global Olprinone Hydrochloride Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Olprinone Hydrochloride Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Olprinone Hydrochloride Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Olprinone Hydrochloride Injection Sales by Region (2027-2032)
  5. 6.3 Global Olprinone Hydrochloride Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Olprinone Hydrochloride Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Olprinone Hydrochloride Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Olprinone Hydrochloride Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Olprinone Hydrochloride Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Olprinone Hydrochloride Injection Sales Value (2021-2032)
  12. 6.6.2 North America Olprinone Hydrochloride Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Olprinone Hydrochloride Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Olprinone Hydrochloride Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Olprinone Hydrochloride Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Olprinone Hydrochloride Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Olprinone Hydrochloride Injection Sales Value (2021-2032)
  21. 6.9.2 South America Olprinone Hydrochloride Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Olprinone Hydrochloride Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Olprinone Hydrochloride Injection Sales Value Share by Country, 2025 VS 2032
7 Olprinone Hydrochloride Injection Country-level Sales and Value Analysis
  1. 7.1 Global Olprinone Hydrochloride Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Olprinone Hydrochloride Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Olprinone Hydrochloride Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Olprinone Hydrochloride Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Olprinone Hydrochloride Injection Sales by Country (2027-2032)
  6. 7.4 Global Olprinone Hydrochloride Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Olprinone Hydrochloride Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Olprinone Hydrochloride Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Olprinone Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Olprinone Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Olprinone Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 BioHippo
  2. 8.1.1 BioHippo Company Information
  3. 8.1.2 BioHippo Business Overview
  4. 8.1.3 BioHippo Olprinone Hydrochloride Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 BioHippo Olprinone Hydrochloride Injection Product Portfolio
  6. 8.1.5 BioHippo Recent Developments
  7. 8.2 Cayman Chemical
  8. 8.2.1 Cayman Chemical Company Information
  9. 8.2.2 Cayman Chemical Business Overview
  10. 8.2.3 Cayman Chemical Olprinone Hydrochloride Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Cayman Chemical Olprinone Hydrochloride Injection Product Portfolio
  12. 8.2.5 Cayman Chemical Recent Developments
  13. 8.3 DC Chemicals
  14. 8.3.1 DC Chemicals Company Information
  15. 8.3.2 DC Chemicals Business Overview
  16. 8.3.3 DC Chemicals Olprinone Hydrochloride Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 DC Chemicals Olprinone Hydrochloride Injection Product Portfolio
  18. 8.3.5 DC Chemicals Recent Developments
  19. 8.4 Vinci Biochem srl
  20. 8.4.1 Vinci Biochem srl Company Information
  21. 8.4.2 Vinci Biochem srl Business Overview
  22. 8.4.3 Vinci Biochem srl Olprinone Hydrochloride Injection Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Vinci Biochem srl Olprinone Hydrochloride Injection Product Portfolio
  24. 8.4.5 Vinci Biochem srl Recent Developments
  25. 8.5 Dequan Pharmaceutical (Jiangsu) Co., Ltd.
  26. 8.5.1 Dequan Pharmaceutical (Jiangsu) Co., Ltd. Company Information
  27. 8.5.2 Dequan Pharmaceutical (Jiangsu) Co., Ltd. Business Overview
  28. 8.5.3 Dequan Pharmaceutical (Jiangsu) Co., Ltd. Olprinone Hydrochloride Injection Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Dequan Pharmaceutical (Jiangsu) Co., Ltd. Olprinone Hydrochloride Injection Product Portfolio
  30. 8.5.5 Dequan Pharmaceutical (Jiangsu) Co., Ltd. Recent Developments
  31. 8.6 Sinopharm Rongsheng Pharmaceutical Co., Ltd.
  32. 8.6.1 Sinopharm Rongsheng Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Sinopharm Rongsheng Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Sinopharm Rongsheng Pharmaceutical Co., Ltd. Olprinone Hydrochloride Injection Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Sinopharm Rongsheng Pharmaceutical Co., Ltd. Olprinone Hydrochloride Injection Product Portfolio
  36. 8.6.5 Sinopharm Rongsheng Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Hunan Hengsheng Pharmaceutical Co., Ltd.
  38. 8.7.1 Hunan Hengsheng Pharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Hunan Hengsheng Pharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Hunan Hengsheng Pharmaceutical Co., Ltd. Olprinone Hydrochloride Injection Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Hunan Hengsheng Pharmaceutical Co., Ltd. Olprinone Hydrochloride Injection Product Portfolio
  42. 8.7.5 Hunan Hengsheng Pharmaceutical Co., Ltd. Recent Developments
  43. 8.8 Jilin Sichang Pharmaceutical Co., Ltd.
  44. 8.8.1 Jilin Sichang Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Jilin Sichang Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Jilin Sichang Pharmaceutical Co., Ltd. Olprinone Hydrochloride Injection Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Jilin Sichang Pharmaceutical Co., Ltd. Olprinone Hydrochloride Injection Product Portfolio
  48. 8.8.5 Jilin Sichang Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 Jichuang Pharmaceutical Group Co., Ltd.
  50. 8.9.1 Jichuang Pharmaceutical Group Co., Ltd. Company Information
  51. 8.9.2 Jichuang Pharmaceutical Group Co., Ltd. Business Overview
  52. 8.9.3 Jichuang Pharmaceutical Group Co., Ltd. Olprinone Hydrochloride Injection Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Jichuang Pharmaceutical Group Co., Ltd. Olprinone Hydrochloride Injection Product Portfolio
  54. 8.9.5 Jichuang Pharmaceutical Group Co., Ltd. Recent Developments
  55. 8.10 Ruiyang Pharmaceutical Co., Ltd.
  56. 8.10.1 Ruiyang Pharmaceutical Co., Ltd. Company Information
  57. 8.10.2 Ruiyang Pharmaceutical Co., Ltd. Business Overview
  58. 8.10.3 Ruiyang Pharmaceutical Co., Ltd. Olprinone Hydrochloride Injection Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Ruiyang Pharmaceutical Co., Ltd. Olprinone Hydrochloride Injection Product Portfolio
  60. 8.10.5 Ruiyang Pharmaceutical Co., Ltd. Recent Developments
  61. 8.11 Shandong Qidu Pharmaceutical Co., Ltd.
  62. 8.11.1 Shandong Qidu Pharmaceutical Co., Ltd. Company Information
  63. 8.11.2 Shandong Qidu Pharmaceutical Co., Ltd. Business Overview
  64. 8.11.3 Shandong Qidu Pharmaceutical Co., Ltd. Olprinone Hydrochloride Injection Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Shandong Qidu Pharmaceutical Co., Ltd. Olprinone Hydrochloride Injection Product Portfolio
  66. 8.11.5 Shandong Qidu Pharmaceutical Co., Ltd. Recent Developments
  67. 8.12 Shanxi Deyuantang Pharmaceutical Co., Ltd.
  68. 8.12.1 Shanxi Deyuantang Pharmaceutical Co., Ltd. Company Information
  69. 8.12.2 Shanxi Deyuantang Pharmaceutical Co., Ltd. Business Overview
  70. 8.12.3 Shanxi Deyuantang Pharmaceutical Co., Ltd. Olprinone Hydrochloride Injection Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Shanxi Deyuantang Pharmaceutical Co., Ltd. Olprinone Hydrochloride Injection Product Portfolio
  72. 8.12.5 Shanxi Deyuantang Pharmaceutical Co., Ltd. Recent Developments
  73. 8.13 Shenyang Shuangding Pharmaceutical Co., Ltd.
  74. 8.13.1 Shenyang Shuangding Pharmaceutical Co., Ltd. Company Information
  75. 8.13.2 Shenyang Shuangding Pharmaceutical Co., Ltd. Business Overview
  76. 8.13.3 Shenyang Shuangding Pharmaceutical Co., Ltd. Olprinone Hydrochloride Injection Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Shenyang Shuangding Pharmaceutical Co., Ltd. Olprinone Hydrochloride Injection Product Portfolio
  78. 8.13.5 Shenyang Shuangding Pharmaceutical Co., Ltd. Recent Developments
  79. 8.14 Wuhu Yangyan Pharmaceutical Co., Ltd.
  80. 8.14.1 Wuhu Yangyan Pharmaceutical Co., Ltd. Company Information
  81. 8.14.2 Wuhu Yangyan Pharmaceutical Co., Ltd. Business Overview
  82. 8.14.3 Wuhu Yangyan Pharmaceutical Co., Ltd. Olprinone Hydrochloride Injection Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Wuhu Yangyan Pharmaceutical Co., Ltd. Olprinone Hydrochloride Injection Product Portfolio
  84. 8.14.5 Wuhu Yangyan Pharmaceutical Co., Ltd. Recent Developments
  85. 8.15 Zhongfu Pharmaceutical Co., Ltd.
  86. 8.15.1 Zhongfu Pharmaceutical Co., Ltd. Company Information
  87. 8.15.2 Zhongfu Pharmaceutical Co., Ltd. Business Overview
  88. 8.15.3 Zhongfu Pharmaceutical Co., Ltd. Olprinone Hydrochloride Injection Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Zhongfu Pharmaceutical Co., Ltd. Olprinone Hydrochloride Injection Product Portfolio
  90. 8.15.5 Zhongfu Pharmaceutical Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Olprinone Hydrochloride Injection Value Chain Analysis
  2. 9.1.1 Olprinone Hydrochloride Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Olprinone Hydrochloride Injection Sales Mode & Process
  6. 9.2 Olprinone Hydrochloride Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Olprinone Hydrochloride Injection Distributors
  9. 9.2.3 Olprinone Hydrochloride Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst